ROCIO HERNANDEZ: Open Payments
NPI 1174293831 · GLEN ELLYN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 24 payments from 11 companies in 2025. Trend: 2023 $19 · 2024 $206 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| ABBVIE INC. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Alkermes, Inc. | 3 | $43 |
| Noven Therapeutics, LLC | 2 | $37 |
| Corium, LLC | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $21 |
Products named: VRAYLAR, REXULTI, SPRAVATO, Auvelity, INVEGA SUSTENNA, CAPLYTA, Xelstrym, ARISTADA.
Industry payments across IL — which companies pay providers there.
